ß-Carbolines and N-Methylation Underlying Parkinson’s Disease

  • Kazuo Matsubara
  • Koji Aoyama
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Abstract

The discovery of MPTP leads to the hypothesis that Parkinson’s disease (PD) is may be initiated or precipitated by endogenous toxins by the mechanism similar to that of MPTP in genetically-predisposed individuals. The higher cerebrospinal fluid (CSF) levels of N-methylated azaheterocyclic amines, such as ß-carbolines (ßCs) and tetrahydroisoquinoline, have been found in PD patients. Thus, there is a hypothesis to influence the pathogenesis of PD, that is, the excess enzyme activity to activate neurotoxins, such as N-methyltransferase, might be higher in PD patients (Matsubara et al., 1998a).

Keywords

Tyrosine Hydroxylase Lumbar Cerebrospinal Fluid Endogenous Toxin Aldehyde Oxidase Activity Endogenous Neurotoxin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albores, R., Neafsey, E. J., Drucker G., Fields J. Z., and Collins M. A., 1990, Mitochondrial respiratory inhibition by N-methylated-β-carboline derivatives structurally resembling N-methyl-4-phenylpyridine, Proc. Natl. Acad. Sci. USA 87:9368.PubMedCrossRefGoogle Scholar
  2. Aoyama, K., Matsubara, K., Okada, K., Fukushima, S., Shimizu, K., Yamaguchi, S., Uezono, T., Satomi, M., Hayase, N., Ohta, S., Shiono, H. and Kobayashi, S., 2000, N-Methylation ability for azaheterocyclic amines is higher in Parkinson’s disease: nicotinamide loading test, J. Neural. Transm. 107:985.PubMedCrossRefGoogle Scholar
  3. Aoyama, K., Matsubara, K., Kondo, M., Murakawa, Y., Suno, M., Yamashita, K., Yamaguchi, S. and Kobayashi, S., 2001, Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson’s disease, Neurosci. Lett., 298:78.PubMedCrossRefGoogle Scholar
  4. Collins, M. A., Neafsey, E. J., Matsubara, K., Cobuzzi, R. J. Jr and Rollema, H., 1992, Indole-N-methylated ß- carbolinium ions as potential brain-bioactivated neurotoxins, Brain Res. 570:154.PubMedCrossRefGoogle Scholar
  5. Drucker, G., Raikoff, K., Neafsey, E. J. and Collins, M. A., 1990, Dopamine uptake inhibitory capacities of ß-carboline and 3, 4-dihydro-β-carboline analogs of N-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP) oxidation products, Brain Res. 509:125.PubMedCrossRefGoogle Scholar
  6. Gearhart, D. A., Collins, M. A., Lee, J. M. and Neafsey, E. J., 2000, Increased β-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson’s disease, Neurobiol. Dis. 7:201.PubMedCrossRefGoogle Scholar
  7. Green, S., Buttrum, S., Molloy, H., Steventon, G., Sturman, S., Waring, R., Pall, H. and Williams, A., 1991, N-methylation of pyridines in Parkinson’s disease. Lancet 338:120.PubMedCrossRefGoogle Scholar
  8. Matsubara, K., Neafsey, E. J. and Collins, M. A., 1992, Novel S-adenosylmethionine-dependent indole-N-methylation of β-carbolines in brain particulate fractions, J Neurochem. 59:511.PubMedCrossRefGoogle Scholar
  9. Matsubara, K., Collins, M. A., Akan, E. A., Dcebuchi, J., Neafsey, E. J., Kagawa, M., and Shiono, H., 1993, Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain, Brain Res. 610: 90.PubMedCrossRefGoogle Scholar
  10. Matsubara, K., Kobayashi, S., Kobayashi, Y., Yamashita, K., Koide, H., Hatta, M., Iwamoto, K., Tanaka, O. and Kimura, K., 1995a, β-Carbolinium cations, endogenous MPP+ analogs, in the lumber cerebrospinal fluid of parkinsonian patients, Neurology 45:2240.PubMedCrossRefGoogle Scholar
  11. Matsubara, K., Idzu, T., Kobayashi, Y., Nakahara, D., Maruyama, W., Kobayashi, S., Kimura, K. and Naoi M., 1995b, N-Methyl-4-phenylpyridinium and an endogenously formed analog, N-methylated ß-carbolinium, inhibit striatal tyrosine hydroxylation in freely moving rats, Neurosci. Lett. 199:19.CrossRefGoogle Scholar
  12. Matsubara K., Idzu T., Kobayashi Y., Gonda T., Okunishi H., and Kiumura K., 1996, Differences in dopamine efflux induced by MPP and β-carbolinium in the striatum of concious rats, Eur. J. Pharmacol. 315:145.PubMedCrossRefGoogle Scholar
  13. Matsubara, K., 1998a, Bioactivation of Azaheterocyclic Amines via S-Adenosyl-L-Methionine-Dependent N- Methyltransferase, in, Pharmacology of Endogenous Neurotoxins, A. Mozel, ed., Birkhäuser, Boston, pp. 191–208.CrossRefGoogle Scholar
  14. Matsubara, K., Gonda, T., Sawada, H., Uezono, T., Kobayashi, Y., Kawamura, T., Ohtaki, K., Kimura, K. and Akaike, A., 1998b, Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson’s disease, J. Neurochem. 70:72.Google Scholar
  15. Matsubara K., Senda T., Uezono T., Fukushima S., Ohta S., Igarashi K., Naoi M., Yamashita Y., Ohtaki K., Hayase N., Akutsu, S. and Kimura, K., 1998c, Structural significance of azaheterocyclic amines related to Parkinson’s disease for dopamine transporter. Eur. J. Pharmacol. 348: 77.PubMedCrossRefGoogle Scholar
  16. Matsubara, K., Senda, T., Uezono, T., Awaya, T., Ogawa, S., Chiba, K., Shimizu, K., Hayase, N. and Kimura, K., 2001, L-Deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP+ and ß-carbolinium: a microdialysis study in rats, Neurosci. Lett. 302:65.PubMedCrossRefGoogle Scholar
  17. Naoi, M., Maruyama, W., Nakao, N., Ibi, T, Sahashi, K., Benedetti, M. S., 1998, (R)Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes, Ann Neurol. 43:212.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Kazuo Matsubara
    • 1
  • Koji Aoyama
    • 2
  1. 1.Dept. of Hospital Pharm. & Pharmacol.Asahikawa Med. CollegeAsahikawaJapan
  2. 2.Dept. of Internal Med. IIIShimane Med. Univ.IzumoJapan

Personalised recommendations